Editorial: an argument for low-dose thiopurine allopurinol combination use as first-line therapy in inflammatory bowel disease—authors’ reply

Research output: Contribution to journalEditorialOtherpeer-review

Original languageEnglish
Pages (from-to)98-99
Number of pages2
JournalAlimentary Pharmacology and Therapeutics
Volume48
Issue number1
DOIs
Publication statusPublished - Jul 2018
Externally publishedYes

Cite this